Colorectal cancer resources for healthcare providers
Colorectal cancer (CRC) is common, affecting approximately 140,000 individuals annually in the United States. The average person has a 5% lifetime risk to develop CRC. As with all cancers, CRC develops due to a combination of genetic, biologic, and environment factors interacting together. Approximately 5-10% cases of CRC are due to a hereditary syndrome, where a single gene alteration conveys a high risk of CRC and sometimes other cancers. The resources below provide opportunities to learn about hereditary colorectal cancer syndromes, how to use family history to assess risk level, genetic testing, using genetic information to inform management, and communicating with patients about genetic risk.
Lynch Syndrome Factsheet. Describes the clinical features, diagnosis, testing and genetics of Lynch syndrome (hereditary nonpolyposis colorectal cancer).
Familial Adenomatous Polyposis Factsheet. Describes the clinical features, diagnosis, testing and genetics of familial adenomatous polyopsis (FAP) and attenuated FAP.
MUTYH-Associated Adenomatous Polyposis Factsheet. Describes the clinical features, diagnosis, testing and genetics of MUTYH-associated polyposis (MAP).
Genetically Related Cancers Tool. Lists the associated cancers and unique characteristics of common cancer susceptibility genes.
Targeted Colorectal and Polyp Family History Tool. Lists key questions and guidance for collecting a family history targeted toward colorectal cancer.
Cancer Risk Assessment Tool. Helps identify red flags and stratify cancer risk based on family history.
Colorectal Cancer Screening Guidelines Factsheet. Summarizes professional society guidance about screening for individuals at average, increased, and high risk of colorectal cancer.
Family History Collection Tips & Tools. Provides tips, resources, and tools for family history collection in clinical practice.
Family History Questionnaire. A collection form for medical family history data that can be printed and used in clinical practice.
Pedigree Tool. A template to record a pedigree with standard pedigree nomenclature.
Hereditary Cancer Management Guidelines Factsheet. Lists and links to evidence-based guidelines and professional society publications that address management of hereditary and familial cancer.
Genetic Testing Methods eBook. Provides information about different genetic testing methods currently used in testing for hereditary cancer syndromes (enhanced e-book available for download).
Communicating Risk Factsheet. Outlines key points to consider when communicating risk to patients.
Pretest Counseling Key Points Factsheet. Outlines key points to address during pretest counseling.
Components of a Cancer Genetic Counseling Session Factsheet. Discusses the core components of a cancer genetic counseling session.
Cancer Genetic Services in Maine and Connecticut Tool. Lists available cancer genetic services in Maine and Connecticut.
GINA Discussion Guide. Provides talking points and key information about genetic discrimination and the Genetic Information Nondiscrimination Act (GINA), which protects individuals from the misuse of genetic information in health insurance and employment.
Free, self-directed programs for continuing education credit.
Practice evaluating the fit between a patient's history and a particular genetic test for hereditary colorectal cancer syndromes.
Access CME Module | Access CNE Module
Practice asking the right questions to elicit enough information to assess family history disease risk and get tools to implement your skills.
Access CME Module | Access CNE Module
Analyze family histories and classify patients' risk into average, increased (moderate), or high risk for cancer.
Access CME Module | Access CNE Module
Practice determining appropriate management based on family history risk stratification.
Access CME Module | Access CNE Module
Practice identifying risk factors in case scenarios and receive tools to help make this task easy to implement in your practice.
Access CME Module | Access CNE Module
Practice deciding when and if genetic testing is appropriate given a patient's clinical and personal context.
Access CME Module | Access CNE Module
Practice interpreting genetic testing results within a patient's specific context.
Access CME Module | Access CNE Module
Practice weighing the benefits, risks, and limitations of different tests within specific patient contexts.
Access CME Module | Access CNE Module
Immunologically humanized NSGTM and its variant strains are a powerful system that facilitates cutting-edge in vivo preclinical testing of...
A JAX team developed CUP-AI-Dx, a machine learning tool that uses RNA sequence data for analysis. The researchers show that...
Presence of MSI-H in a dMMR tumor is correlated with the formation of novel small proteins that are recognized by T cells in...
Key features and cancer risks associated with common hereditary cancer syndromes.
The case is to help clinicians recognize personal and family history characteristics that determine which patients should be...
The case is to help clinicians understand how to use a variant of uncertain clinical significance on a genomic tumor test...
Learn how mouse selection is critical for efficient propagation of primary human tumors and the maintenance of its microenvironment,...
Cancer is a heterogeneous collection of diseases characterized by uncontrolled cell growth and spread to distant organs. In this series, we...
Cancer is a heterogeneous collection of diseases characterized by uncontrolled cell growth and spread to distant organs. In this series, we...
During this presentation, Dr. Bankert discusses the optimal design of patient derived xenografts (PDX) to study cancer pathogenesis and...
Cancer is a heterogeneous collection of diseases characterized by uncontrolled cell growth and spread to distant organs. In this series, we...
PDX models provide researchers with the ability to work with tumors directly from patients within a living (in vivo) system, making them a...
Free online CME for physicians: Practice weighing the benefits, risks, and limitations of different genetic tests within specific patient...
In this webinar, our panel of experts will discuss the successes and caveats of using humanized mouse models to understand disease biology...
Could early colorectal cancer screening recommended by the American Cancer Society identify more people at high risk for...
Key points to consider when communicating risk to patients.
We use cookies to personalize our website and to analyze web traffic to improve the user experience. You may decline these cookies although certain areas of the site may not function without them. Please refer to our privacy policy for more information.
Allow essential cookies
Required for basic site operations.
Allow analytics cookies
Used to analyze web traffic to improve the user experience.
Allow marketing cookies
Used to deliver personalized information and tailor communications.